Navigating the Canadian copyright scene presents a complex challenge. To be blunt , dimethyltryptamine (copyright) remains entirely against the law across the country . There are no sanctioned sources accessible for acquisition . However, perhaps , the regulated status of psilocybin, and the growing acceptance of copyright therapy , have prompted c